Search results
Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.
Regeneron is a leading biotechnology company using the power of science to bring new medicines to patients in need. Explore Regeneron's global presence.
Founded and led for 35 years by physician-scientists, Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Learn more.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Find addresses and contact information for Regeneron's offices in North America, Europe and Asia. Our antibody combination is not currently authorized for use in any U.S. region. Please refer to the authorized Fact Sheet and FDA statement for additional details.
Monitor SARS-CoV-2 variants with Regeneron’s COVID-19 Dashboard. Refreshed daily with new genomes and associated patient metadata. Learn how Regeneron is actively working on testing existing medicines and developing new antibodies to combat the COVID-19 pandemic.
Learn about the many Regeneron-invented technologies accelerating drug discovery and development such as VelociGene®, VelociMouse®, VelocImmune® and more.
4 days ago · REGN | Complete Regeneron Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Jan 25, 2024 · Dupixent is now the first and only medicine approved in the U.S. specifically indicated to treat these patients. This approval expands the initial FDA approval for EoE in May 2022 for patients aged 12 years and older, weighing at least 40 kg.
Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock quote, history, news and other vital information to help you with your stock trading and investing.
